Thank you !

Access info about Speech Recognition - Front-End EMR on your dashboard or bookmark under

(Your Products / Your Organization's Products)

We are currently researching Speech Recognition - Front-End EMR.

Will you help us?

Take A Survey

Premium Reports
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Speech Recognition (Front-End EMR) Segment Highlight 2020
|
2020
Front-End Speech 2018
|
2018
Front-End Speech
|
2015
Speech Recognition 2013
|
2013
Speech Recognition 2010
|
2010
Speech Recognition 2008
|
2008
Speech Recognition 2007
|
2007
Speech Recognition Report 2006
|
2006

Related Segments

Related Products

Related Vendors

 End chart zoom
Front-End Speech 2014 Front-End Speech 2014
* A page refresh may be necessary to see the updated image

Front-End Speech 2014
Functionality Doesn’t Trump Physician Resistance

author - Boyd Stewart
Author
Boyd Stewart
 
June 12, 2014 | Read Time: 3  minutes

Current Time Inside Cache Tag Helper: 10/16/2021 4:15:34 PM and Model.reportId = 940

Front-end speech (FES) tools are gaining momentum with providers looking to benefit from reduced transcription costs, shorter documentation times, and more complete patient narratives. Nuance continues to lead in market share by an extensive margin, although M*Modal and Dolbey have gained ground. Speaking with 56 healthcare providers, KLAS uncovered who providers have purchased and why, the challenges and strategies of FES expansion, and how the FES vendors are performing.

Thank you !

Access info about Speech Recognition - Front-End EMR on your dashboard or bookmark under

(Your Products / Your Organization's Products)

We are currently researching Speech Recognition - Front-End EMR.

Will you help us?

Take A Survey

HtmlReportContent Current Time Inside Cache Tag Helper: 10/16/2021 4:15:34 PM and Model.reportId= 940 and Model.HtmlReportContent_LastWriteTimeUtcInTicks=637498872296722198

most challenging areas for front end speech adoption

WORTH KNOWING

HIGH OPTIMISM THAT “CLOUD-BASED” MAY RESOLVE PHYSICIAN RESISTANCE:

Overwhelmingly, providers from all three vendors measured in this report indicated physician adoption to be the biggest hurdle to successful deployment. Providers purchasing Fluency Direct and those looking forward to Nuance’s cloud-based offering hope these solutions will lead to significantly better adoption, but thus far the easier learning curve and implementations have not outweighed physician resistance to workflow changes.

SPEECH ENGINE IS A COMMODITY; NUANCE’S COST AND SUPPORT OPENING THE DOOR FOR COMPETITION:

In general, providers feel that all three vendors in this report are comparable in terms of product performance. Providers that have switched from Nuance to Dolbey or M*Modal said they left Nuance for better up-front costs and/or support. However, long-standing relationships, industry reputation, and EMR collaboration continue to draw new customers to Nuance and to keep long-time customers from leaving.

WINNING FORMULA = EMR + SPEECH: CERNER CUSTOMERS SEE THE GREATEST BENEFIT:

By pairing speech functionality with EMR front-end tools, providers see a higher impact in every category measured in this study. Epic clients find that transcription costs are highly impacted by the use of their EMR smart tools alone and minimally impacted by the addition of speech tools. With Cerner, providers see minimal impact from EMR tools alone but high impact on all three areas measured when they add FES tools.

benefits of front end speech with epic and cernerthere are challenges with getting adoptionoverall performance

BEST PRACTICES 

1. DETERMINE ORGANIZATIONAL STRATEGY:

Have a plan surrounding deployment, adoption, and EMR integration to quickly maximize efficiency and value.

2. BUILD MACROS AND TEMPLATES FOR COMPLEX ENVIRONMENTS:

Especially in highly structured environments, templates and macros bring added convenience to users. Many find success with a hybrid of these and front-end speech tools.

3. RECRUIT PHYSICIAN CHAMPIONS:

Physician champions help foster physician buy-in despite workflow disruption and ultimately smooth the transition for users.

4. PLAN SUFFICIENT TIME TO TRAIN:

Lack of training hurts adoption; users who are not sufficiently trained become very frustrated.

BOTTOM LINE ON VENDORS

DOLBEY:

Fusion SpeechEMR received highest overall rating in this study. Dolbey got high marks for exceptional service/support and low cost, and customers rated them highest in ability to capture unique speech patterns. Although a few providers mentioned working through a learning curve before obtaining ease of use, several clients listed ease of use, implementation process, and lower up-front costs as decisive purchasing factors. By far the smallest of the FES vendors in this report, Dolbey was only considered by two M*Modal/Nuance customers.

M*MODAL:

Fluency Direct had the most clients cite price point as deciding factor. Cloud-based technology offering short learning curve, out-of-the-box functionality, and mobility creates optimism for better physician adoption. Across the board, most M*Modal customers saw significant reduction in transcription costs, although Epic customers tended to give much of that credit to Epic tools. Some providers expressed concern for stability after M*Modal filed for Chapter 11 in March 2014, although M*Modal recently won court approval to restructure.

NUANCE:

Dragon Medical 360 NE is highest rated for reducing transcription costs. Significantly more expensive than Dolbey or M*Modal, which deters some providers. However, industry reputation, extensive technology portfolio, and progressive development continue to attract new customers and keep many long-term customers who have seen Nuance’s products improve over the years. Several providers expressed optimism surrounding Nuance’s upcoming cloud-based solution. Many providers complained of poor service/support.

what are your future plans

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.